跳至主要内容
临床试验/NCT01991444
NCT01991444已完成不适用

Registry Study to Evaluate the Predictive Value of a Comprehensive Geriatric Assessment With Regard to the Outcome of a Transcatheter Aortic Valve Implantation.

Institut für Pharmakologie und Präventive Medizin3 个研究点 分布在 3 个国家目标入组 72 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
72
试验地点
3
主要终点
Comprehensive geriatric assessment

研究概览

简要总结

Registry study to evaluate the predictive value of a comprehensive geriatric assessment with regard to the outcome of a transcatheter aortic valve Implantation.

It will be evaluated which parts of the comprehensive geriatric assessment (CGA) are best suited to predict the therapeutic success of a heart valve Implantation in elderly ( > 80 years) Patient. Possible participants are all Patient of 80 years or above for whom the implantation of a Edwards Sapien XT aortic valve is planned

详细描述

Transcatheter Aortic Valve Implantation Registry with Comprehensive Geriatric Assessment

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
80 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled TAVI using Edwards SAPIEN XT Transcatheter Heart Valve
  • Compliance with the indications of the instructions for use
  • Age of at least 80 years
  • Written informed consent

排除标准

  • Presence of contraindications as to the Instructions for Use
  • No possibility for a follow-up

结局指标

主要结局

Comprehensive geriatric assessment

时间窗: Baseline and 3 months

Demonstrate CGA changes within 3 months after TAVI The CGA is an array of several different assessments with regard to frailty, comorbidities, administrative data (Silver code), Quality of life etc. Every Patient will undergo a CGA at baseline and 3 months after TAVI. Data will be analyzed to determine changes in CGA results.

次要结局

  • Score development(after 3 months)
  • predictive Value of CGA Tavi(baseline)

研究者

发起方
Institut für Pharmakologie und Präventive Medizin
申办方类型
Network
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验